(Q38068962)

28 August 2017

1 reference

title

Recommendations for identifying Crohn's disease patients with poor prognosis (English)

1 reference

28 August 2017

0 references

Peter L Lakatos

5

0 references

author name string

Pal Miheller

1

1 reference

28 August 2017

Lajos S Kiss

2

1 reference

28 August 2017

Mark Juhasz

3

1 reference

28 August 2017

Michael Mandel

4

1 reference

28 August 2017

publication date

1 January 2013

1 reference

Expert Review of Clinical Immunology

28 August 2017

published in

1 reference

28 August 2017

volume

9

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

65-75; quiz 76

1 reference

Recent trends in the epidemiology of inflammatory bowel diseases: up or down?

28 August 2017

cites work

1 reference

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

21 January 2018

1 reference

High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study

21 January 2018

1 reference

Effects of cigarette smoking on the long-term course of Crohn's disease.

21 January 2018

1 reference

Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends

21 January 2018

1 reference

Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006.

21 January 2018

1 reference

A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.

21 January 2018

1 reference

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

21 January 2018

1 reference

Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease

21 January 2018

1 reference

Implementing changes in clinical practice to improve the management of Crohn's disease

21 January 2018

1 reference

Natural history of pediatric Crohn's disease: a population-based cohort study

21 January 2018

1 reference

Frequency of glucocorticoid resistance and dependency in Crohn's disease

21 January 2018

1 reference

Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease

21 January 2018

1 reference

Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine

21 January 2018

1 reference

Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates

21 January 2018

1 reference

Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease

21 January 2018

1 reference

Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative

21 January 2018

1 reference

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

21 January 2018

1 reference

The role of smoking in Crohn's disease as defined by clinical variables

21 January 2018

1 reference

Smoking in Crohn's disease: effect on localisation and clinical course

21 January 2018

1 reference

Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice

21 January 2018

1 reference

Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel disease

21 January 2018

1 reference

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)

21 January 2018

1 reference

Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestiv

21 January 2018

1 reference

Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease

21 January 2018

1 reference

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort

21 January 2018

1 reference

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.

21 January 2018

1 reference

Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease

21 January 2018

1 reference

Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial

21 January 2018

1 reference

Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease

21 January 2018

1 reference

Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease.

21 January 2018

1 reference

C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study

21 January 2018

1 reference

High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn's disease: a marker for patient classification?

21 January 2018

1 reference

Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease

21 January 2018

1 reference

Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease

21 January 2018

1 reference

Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease

21 January 2018

1 reference

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse

21 January 2018

1 reference

Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies

21 January 2018

1 reference

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

21 January 2018

1 reference

Serologic antiglycan antibodies in inflammatory bowel disease.

21 January 2018

1 reference

Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families.

21 January 2018

1 reference

Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.

21 January 2018

1 reference

Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease

21 January 2018

1 reference

Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression

21 January 2018

1 reference

Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.

21 January 2018

1 reference

Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology?

21 January 2018

1 reference

Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort

21 January 2018

1 reference

Increased immune reactivity predicts aggressive complicating Crohn's disease in children

21 January 2018

1 reference

Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior

21 January 2018

1 reference

New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort

21 January 2018

1 reference

Anti-microbial antibodies in celiac disease: trick or treat?

21 January 2018

1 reference

Characterization of changes in serum anti-glycan antibodies in Crohn's disease--a longitudinal analysis

21 January 2018

1 reference

The molecular classification of the clinical manifestations of Crohn's disease

21 January 2018

1 reference

Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations

21 January 2018

1 reference

Common variants at five new loci associated with early-onset inflammatory bowel disease

21 January 2018

1 reference

Association of a functional variant in the Wnt co-receptor LRP6 with early onset ileal Crohn's disease

21 January 2018

1 reference

Genetic risk profiling and prediction of disease course in Crohn's disease patients

21 January 2018

1 reference

Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis

21 January 2018

1 reference

Benefits and risks of tight glucose control in critically ill adults: a meta-analysis

21 January 2018

1 reference

Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations

21 January 2018

1 reference

Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort

21 January 2018

1 reference

Infliximab, azathioprine, or combination therapy for Crohn's disease

21 January 2018

1 reference

Mutations in IRGM are associated with more frequent need for surgery in patients with ileocolonic Crohn's disease

21 January 2018

1 reference

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECI.12.86

1 reference

28 August 2017

1 reference